SHARON HARPER: Open Payments
NPI 1093856882 · PLAYA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 40 payments from 7 companies in 2025. Trend: 2023 $299 · 2024 $1,961 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $504 |
| Janssen Pharmaceuticals, Inc | 6 | $277 |
| E.R. Squibb & Sons, L.L.C. | 5 | $197 |
| Neurocrine BioSciences, Inc. | 6 | $191 |
| ABBVIE INC. | 7 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Alkermes, Inc. | 1 | $27 |
Products named: UZEDY, INVEGA SUSTENNA, COBENFY, INGREZZA, AUSTEDO XR, VRAYLAR, CAPLYTA, ARISTADA.
Industry payments across CA — which companies pay providers there.
